N/A Completed N=70 Randomized Single-blind Treatment

Battlefield Auricular Acupuncture for Control of Post-partum Pain

Source: ClinicalTrials.gov NCT02526186 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2024

Primary outcomePrimary: Number of Subjects Who Achieved 50% Sustained Pain Reduction — 0; 0; 2; 6 # of subjects with 50% pain reduction

Summary

We will conduct a randomized controlled trial to determine whether the addition of battlefield auricular acupuncture to standard of care is effective for control of postpartum pain for mothers in the immediate post-partum period. Post-partum patients (DoD beneficiaries) 18 years or older, regardless of gravida/parity, who plan to have a childbirth in a hospital setting will be offered the opportunity to participate in the study through PCM referrals and posted advertisements. After a minimum of 6 hours post-vaginal delivery or 24 hours post caesarean section subjects will be given treatment according to their randomization group. Subjects will be assessed on pain control, overall satisfaction with pain management, and the amount of pharmacological pain medications used. Safety of measures will also be assessed to include infection rates, syncope, vertigo, and hypotension.

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Subjects Who Achieved 50% Sustained Pain Reduction	0; 0; 2; 6; 3; 9	—
SECONDARY Morphine Equivalent Use	88; 82	—

Eligibility Criteria

THIS STUDY IS BEING CONDUCTED AT A MILITARY INSTALLATION. YOU MUST HAVE MILITARY INSURANCE IN ORDER TO PARTICIPATE IN THIS STUDY.

Inclusion:

Post-partum female (DoD beneficiaries).
Age 18 years or older
Pain score rating post-delivery of greater or equal to 4/10.

Exclusion:

Absence of one or more ears
Active cellulitis of ear
Ear anatomy precluding identification of acupuncture landmarks
Non-English speaking
Use of Hearing Aids that preclude the use of ear acupuncture
Known allergy to gold

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02526186). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.